Interestingly, in a competing risk regression analysis of 462 incident first cancer cases with 2,417 controls, it was found that a higher fasting GLP-1 level was significantly associated with a lower risk of incident first cancer (sub-hazard ratio 0.90; 95% CI 0.82–0.99; p = 0.022) [75]. This evidence concerns the gene GLP1R and cancer.